Form D · Pharmaceuticals

65 Therapeutics, Inc.

Somerville, MA · CIK 0002047647

Offering snapshot reported Jul 6, 2026 · SEC filing

Reported sold
$6.7M
Offering amount: $6.7M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 21, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.35M$6.7MDec 6, 2024: $4,500,000.00Dec 6, 2024Jul 6, 2026: $6,700,000.00Jul 6, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,500,000 → $6,700,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 6, 2026Amendment$6,700,000$2,200,000vs Dec 6, 20242SEC filing
Dec 6, 2024Initial$4,500,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-531309

Source: Form D, filed Jul 6, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Murthy Chavali Director
Julius Knowles Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
399 Revolution Drive
Somerville, MA, 02145
Phone: 617-784-9147